Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 650 of 715 entries
View as:

A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

Phase: N/A Priority: Normal
NCT ID: NCT00129818 Org: User:
Start: 07/31/04 End: 10/31/05 Due: 10/31/06

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00644059 Org: User:
Start: 11/30/07 End: 08/31/10 Due: 08/31/11

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00121316 Org: User:
Start: 10/31/04 End: 07/31/05 Due: 07/31/06

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00304226 Org: User:
Start: 02/28/06 End: 01/31/07 Due: 01/31/08

A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia

Phase: N/A Priority: Normal
NCT ID: NCT00300287 Org: User:
Start: 02/20/06 End: 06/26/07 Due: 06/26/08

Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00494884 Org: User:
Start: 06/30/07 End: 07/31/08 Due: 07/31/09

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

Phase: N/A Priority: Normal
NCT ID: NCT01281657 Org: User:
Start: 02/28/11 End: 07/31/12 Due: 07/31/13

Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00138541 Org: User:
Start: 10/31/04 End: 04/30/06 Due: 04/30/07

Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00171743 Org: User:
Start: 04/30/04 End: 01/31/06 Due: 01/31/07

Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01568775 Org: User:
Start: 06/30/10 End: 09/30/10 Due: 09/30/11

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

Phase: N/A Priority: Normal
NCT ID: NCT00567996 Org: User:
Start: 11/30/07 End: - Due: -

Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00325429 Org: User:
Start: 04/30/06 End: - Due: -

Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00447694 Org: User:
Start: 02/28/06 End: 11/30/09 Due: 11/30/10

Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00505089 Org: User:
Start: 08/31/07 End: - Due: -

Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00138528 Org: User:
Start: 10/31/04 End: 02/28/06 Due: 02/28/07

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00138554 Org: User:
Start: 11/30/04 End: 07/31/06 Due: 07/31/07

Real World Patient Characteristics and Treatment Patterns From Crizanlizumab Use: Preliminary Analysis From Select Sickle Cell Centers

Phase: N/A Priority: Normal
NCT ID: NCT06662825 Org: User:
Start: 12/13/22 End: 11/01/23 Due: 11/01/24

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Phase: N/A Priority: Normal
NCT ID: NCT00171171 Org: User:
Start: 05/31/04 End: - Due: -

A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00327145 Org: User:
Start: 03/31/06 End: 01/31/07 Due: 01/31/08

A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00154258 Org: User:
Start: 04/30/01 End: 12/31/09 Due: 12/31/10

To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00145275 Org: User:
Start: 12/31/04 End: 10/31/05 Due: 10/31/06

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00567047 Org: User:
Start: 07/31/07 End: - Due: -

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Phase: N/A Priority: Normal
NCT ID: NCT00386763 Org: User:
Start: 08/31/06 End: 03/31/07 Due: 03/31/08

A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00171093 Org: User:
Start: 09/30/04 End: - Due: -

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00350168 Org: User:
Start: 06/30/06 End: 04/30/07 Due: 04/30/08